Clinical Trials Browser

Completed × Carcinoma, Ovarian Epithelial × Standard of Care × Clear all

NCT02107937 2022-05-04

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02107950 2018-08-15

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms